Interest in Bank of New York Mellon Corporation (BK) has picked up after its fourth quarter earnings, where management pointed to record sales, expanded client relationships, and progress in digital assets, AI, and efficiency programs.

Recent trading has cooled slightly after the earnings reaction, with a 7 day share price return of a 3.88% decline and a 1 day move of a 0.76% decline. However, the 90 day share price return of 12.26% and 1 year total shareholder return of 45.16% point to momentum that has built over time as record quarterly results, buybacks and fresh bond issuance have kept Bank of New York Mellon Corporation in focus.

If you are comparing Bank of New York Mellon Corporation with other financial names, it can help to look beyond one stock and review fast growing stocks with high insider ownership as a way to spot more ideas benefiting from strong owner alignment.

With BNY posting higher quarterly earnings and active buybacks at a recent share price of US$119.76, the real question now is whether this represents undervaluation or a market price that already reflects expectations for future growth.

Price-to-Earnings of 15.5x: Is it justified?

At a recent price of US$119.76, BNY is trading on a P/E of 15.5x, which current data suggests is lower than several comparison points, including the broader US market and its own peer group.

The P/E ratio compares the company’s share price to its earnings per share, so it effectively shows how many dollars investors are paying for each dollar of current earnings. For a diversified financial group like Bank of New York Mellon Corporation, which reports high quality earnings and has grown profits over time, the P/E is a quick way to see how that earnings profile is being priced.

Here, the 15.5x P/E is described as good value relative to multiple benchmarks, including the US Capital Markets industry average of 25.5x and a peer average of 30.2x. It also sits below an estimated fair P/E of 16.7x, which indicates a level the market could potentially move toward if sentiment and earnings expectations stay aligned with these comparisons.

Result: Price-to-Earnings of 15.5x (UNDERVALUED)

However, you still need to factor in risks such as shifts in capital markets activity or regulatory changes that could affect Bank of New York Mellon Corporation’s core fee businesses.

Another View Using Our DCF Model

While the 15.5x P/E points to BNY as good value versus peers, our DCF model tells a slightly different story. At a share price of US$119.76 versus an estimated future cash flow value of US$116.99, Bank of New York Mellon Corporation screens as slightly overvalued on this approach.

This gap is small in dollar terms, but it reminds you that earnings based metrics and cash flow based models can send different signals at the same time. The real question is which one you think better reflects how BNY will generate value over the long run.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Bank of New York Mellon for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 881 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Bank of New York Mellon Narrative

If you look at the numbers and reach a different conclusion, or simply prefer to rely on your own work, you can build a complete view in just a few minutes with Do it your way.

A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Bank of New York Mellon.

Looking for more investment ideas?

If you stop with just one company, you might miss other opportunities that fit your style, so keep widening your watchlist and stay ahead of the crowd.

• Target dependable income by checking out these 13 dividend stocks with yields > 3% that may appeal if you want potential cash returns on top of any share price moves.
• Back emerging themes in medicine and diagnostics by reviewing these 109 healthcare AI stocks that connect artificial intelligence with real world healthcare applications.
• Position yourself for potential growth in digital assets by scanning these 19 cryptocurrency and blockchain stocks linked to cryptocurrency and blockchain technologies.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.